← Back to Clinical Trials
Recruiting NCT06856057

NCT06856057 Improving Behavioral Health for Caregivers and Children After Pediatric Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06856057
Status Recruiting
Phase
Sponsor Medical University of South Carolina
Condition Quality of Life
Study Type INTERVENTIONAL
Enrollment 348 participants
Start Date 2025-05-28
Primary Completion 2028-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Caregivers' Aid to Accelerate Recovery after pediatric Emergencies (CAARE)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 348 participants in total. It began in 2025-05-28 with a primary completion date of 2028-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pediatric traumatic injury (PTI) is a public health priority, with more than 125,000 children experiencing injuries that require hospitalization each year. These children, and their caregivers, are affected in many ways that may affect quality of life, emotional and behavioral health, physical recovery, family roles and routines, and academic functioning; yet US trauma centers do not adequately address these outcomes and a scalable national model of care for these families is needed. This proposal builds on prior research from the investigative team to test a technology-assisted, stepped care behavioral health intervention for children (\<12 years) and their caregivers after PTI, CAARE (Caregivers' Aid to Accelerate Recovery after pediatric Emergencies), via a hybrid type I effectiveness-implementation trial with 348 families randomly assigned to CAARE (n=174) vs. guideline-adherent enhanced usual care (EUC) (n=174).

Eligibility Criteria

Inclusion Criteria: * Caregivers (≥18 years old) of children hospitalized with pediatric injury * Children hospitalized with pediatric injury \<12 years old * Screen positive on the ASC-Kids (aged 8-11 years) or PDI Caregiver measure of acute distress. Exclusion Criteria: * A caregiver whose primary language is not English * A cognitive challenge (caregiver or child) that would impair ability to consent * Presence of a self-afflicted injury * Presence of injuries resulting from caregiver abuse or neglect (these patients will follow an alternative treatment path).

Contact & Investigator

Central Contact

Leigh Ridings

✉ ridingle@musc.edu

📞 (843) 792-5146

Principal Investigator

Leigh Ridings, Ph.D.

PRINCIPAL INVESTIGATOR

Medical University of South Carolina

Frequently Asked Questions

Who can join the NCT06856057 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06856057 currently recruiting?

Yes, NCT06856057 is actively recruiting participants. Contact the research team at ridingle@musc.edu for enrollment information.

Where is the NCT06856057 trial being conducted?

This trial is being conducted at Los Angeles, United States, Lexington, United States, Ann Arbor, United States, Houston, United States.

Who is sponsoring the NCT06856057 clinical trial?

NCT06856057 is sponsored by Medical University of South Carolina. The principal investigator is Leigh Ridings, Ph.D. at Medical University of South Carolina. The trial plans to enroll 348 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology